CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib (Q40040623)
Jump to navigation
Jump to search
scientific article published on 5 December 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib |
scientific article published on 5 December 2007 |
Statements
1 reference
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib (English)
1 reference
1 reference
1 reference
Antonio Palumbo
1 reference
Bruce Ruggeri
1 reference
Michael Williams
1 reference
Giulia Costa
1 reference
Dario Ferrero
1 reference
Valentina Giai
1 reference
Silvia Peola
1 reference
Gabriella Pezzoni
1 reference
Cecilia Allievi
1 reference
Nicoletta Pescalli
1 reference
Mara Cassin
1 reference
Stefano di Giovine
1 reference
Paola Nicoli
1 reference
Paola de Feudis
1 reference
Ivan Strepponi
1 reference
Riccardo Ferracini
1 reference
Susan Jones-Bolin
1 reference
Kathryn Hunter
1 reference
Hugh Zhao
1 reference
Celia Berkers
1 reference
Alberto Bernareggi
1 reference
Giorgio Inghirami
1 reference
5 December 2007
1 reference
Identifiers
1 reference